The probability of cost-effectiveness
<p>Abstract</p> <p>Background</p> <p>The study of cost-effectiveness comparisons between competing medical interventions has led to a variety of proposals for quantifying cost-effectiveness. The differences between the various approaches can be subtle, and one purpose o...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2002-03-01
|
Series: | BMC Medical Research Methodology |
Online Access: | http://www.biomedcentral.com/1471-2288/2/5 |
_version_ | 1828274456114495488 |
---|---|
author | Stevens John W O'Hagan Anthony |
author_facet | Stevens John W O'Hagan Anthony |
author_sort | Stevens John W |
collection | DOAJ |
description | <p>Abstract</p> <p>Background</p> <p>The study of cost-effectiveness comparisons between competing medical interventions has led to a variety of proposals for quantifying cost-effectiveness. The differences between the various approaches can be subtle, and one purpose of this article is to clarify some important distinctions.</p> <p>Discussion</p> <p>We discuss alternative measures in the framework of individual, patient-level, incremental net benefits. In particular we examine the probability of cost-effectiveness for an individual, proposed by Willan.</p> <p>Summary</p> <p>We argue that this is a useful addition to the range of cost-effectiveness measures, but will be of secondary interest to most decision makers. We also demonstrate that Willan's proposed estimate of this probability is logically flawed.</p> |
first_indexed | 2024-04-13T06:34:49Z |
format | Article |
id | doaj.art-84d8284e77fc40e2a28758bc1eb7a31b |
institution | Directory Open Access Journal |
issn | 1471-2288 |
language | English |
last_indexed | 2024-04-13T06:34:49Z |
publishDate | 2002-03-01 |
publisher | BMC |
record_format | Article |
series | BMC Medical Research Methodology |
spelling | doaj.art-84d8284e77fc40e2a28758bc1eb7a31b2022-12-22T02:57:57ZengBMCBMC Medical Research Methodology1471-22882002-03-0121510.1186/1471-2288-2-5The probability of cost-effectivenessStevens John WO'Hagan Anthony<p>Abstract</p> <p>Background</p> <p>The study of cost-effectiveness comparisons between competing medical interventions has led to a variety of proposals for quantifying cost-effectiveness. The differences between the various approaches can be subtle, and one purpose of this article is to clarify some important distinctions.</p> <p>Discussion</p> <p>We discuss alternative measures in the framework of individual, patient-level, incremental net benefits. In particular we examine the probability of cost-effectiveness for an individual, proposed by Willan.</p> <p>Summary</p> <p>We argue that this is a useful addition to the range of cost-effectiveness measures, but will be of secondary interest to most decision makers. We also demonstrate that Willan's proposed estimate of this probability is logically flawed.</p>http://www.biomedcentral.com/1471-2288/2/5 |
spellingShingle | Stevens John W O'Hagan Anthony The probability of cost-effectiveness BMC Medical Research Methodology |
title | The probability of cost-effectiveness |
title_full | The probability of cost-effectiveness |
title_fullStr | The probability of cost-effectiveness |
title_full_unstemmed | The probability of cost-effectiveness |
title_short | The probability of cost-effectiveness |
title_sort | probability of cost effectiveness |
url | http://www.biomedcentral.com/1471-2288/2/5 |
work_keys_str_mv | AT stevensjohnw theprobabilityofcosteffectiveness AT ohagananthony theprobabilityofcosteffectiveness AT stevensjohnw probabilityofcosteffectiveness AT ohagananthony probabilityofcosteffectiveness |